Literature DB >> 25645602

CNS cancer: periostin-a new potential target for the treatment of glioblastoma.

Alessia Errico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25645602     DOI： 10.1038/nrclinonc.2015.15

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.

Authors:  Wenchao Zhou; Susan Q Ke; Zhi Huang; William Flavahan; Xiaoguang Fang; Jeremy Paul; Ling Wu; Andrew E Sloan; Roger E McLendon; Xiaoxia Li; Jeremy N Rich; Shideng Bao
Journal:  Nat Cell Biol       Date:  2015-01-12       Impact factor: 28.824
  1 in total
  3 in total

1.  Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma.

Authors:  Lu Chen; Xiangdong Tian; Wenchen Gong; Bo Sun; Guangtao Li; Dongming Liu; Piao Guo; Yuchao He; Ziye Chen; Yuren Xia; Tianqiang Song; Hua Guo
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248

2.  Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.

Authors:  Yang Liu; Fan Li; Feng Gao; Lingxi Xing; Peng Qin; Xingxin Liang; Jiajie Zhang; Xiaohui Qiao; Lizhou Lin; Qian Zhao; Lianfang Du
Journal:  Oncotarget       Date:  2016-06-28

3.  Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells.

Authors:  Rut Valdor; David García-Bernal; Carlos Bueno; Mónica Ródenas; José M Moraleda; Fernando Macian; Salvador Martínez
Journal:  Oncotarget       Date:  2017-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.